Status:
COMPLETED
Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)
Lead Sponsor:
Bayer
Collaborating Sponsors:
LMC Diabetes & Endocrinology
Conditions:
Renal Insufficiency, Chronic
Eligibility:
All Genders
18+ years
Brief Summary
In this survey study, researchers want to find out more about how physicians are treating patients diagnosed with reduced kidney function (chronic kidney disease, CKD) and high blood sugar level (type...
Detailed Description
The primary objective in this study is to assess the awareness, values and preferences of patients and physicians with respect to the risks, consequences and management of chronic kidney disease (CKD)...
Eligibility Criteria
Inclusion
- For patient cohort:
- Diagnosis of type 2 diabetes
- eGFR \< 60 ml/min per 1.73 m2 (measured within the last year) OR eGFR ≥ 60 ml/min per 1.73 m2 and uACR ≥ 2 (measured within the last year)
- No documented non-diabetic etiology for renal disease
- For physician cohort:
- Licensed general practitioner, endocrinologist or nephrologist
- Currently providing care for patients with chronic kidney disease and type 2 diabetes
Exclusion
- Patients with chronic kidney disease and type 2 diabetes who are physicians
- Physicians with chronic kidney disease and type 2 diabetes
Key Trial Info
Start Date :
September 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04498156
Start Date
September 16 2020
End Date
April 30 2021
Last Update
April 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Facilities
Multiple Locations, Canada